← FDA Drug Approvals (Drugs@FDA)

DEFEROXAMINE MESYLATE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: FRESENIUS KABI USA · Approved 2009-09-15

Drug application

FDA Application #
ANDA078718
Application type
Abbreviated New Drug Application (Generic)
Brand name
DEFEROXAMINE MESYLATE
Generic name
DEFEROXAMINE MESYLATE
Active ingredients
DEFEROXAMINE MESYLATE
Dosage form
INJECTABLE
Route
INJECTION
Marketing status
Prescription
Sponsor
FRESENIUS KABI USA
Manufacturer
Fresenius Kabi USA, LLC
First approval
2009-09-15

Source

Authoritative
Drugs@FDA application overview
Machine
JSON-LD · Markdown